Archive for the 'Drugs and Medications' Category

New Anti-AIDS pill under development

Scientists are developing an anti-AIDS pill that can be taken before sex and prevent transmission of the deadly disease.
The successful development of such a treatment would be controversial because it raises ethical questions about the circumstances in which the pill should be taken.
Experts in the disease, which claimed two million lives last year, are involved [...]

Self-Dosing Pain Medications - be careful!

Allowing patients to control their own pain medication intravenously is four times more likely to cause the patient harm than other medications, a new study says.
The report, published in the December issue of The Joint Commission Journal on Quality and Patient Safety, shows that most mistakes involving intravenous patient-controlled analgesia (PCA) resulted from either [...]

Serevent and Foradil asthma drugs may be risky

The risks of two widely used asthma drugs outweigh their benefits for both children and adults, a U.S. Food and Drug Administration advisory panel said Thursday.
The health panel targeted GlaxoSmithKline’s Serevent and Foradil, made jointly by Novartis AG and Schering-Plough, for restrictions, but it excluded Advair, Glaxo’s biggest-selling drug in the class of medications known [...]

Inhaled insulin Exubera may cause lung cancer

US drugmakers Pfizer Inc and Nektar Therapeutics on Wednesday warned of cases of lung cancer in clinical trials of their inhaled insulin Exubera.
The findings led Nektar to announce it was abandoning its search for a new marketing partner for the troubled drug, effectively signaling Exubera’s demise after entering the market in January 2006.
Pfizer, the world’s [...]

Viagra’s 10th anniversary

Ten years ago this month the lives of millions of men and women were changed almost overnight by the advent of a little blue pill — the first oral treatment for impotence.
Viagra, developed by accident by scientists at Pfizer Laboratories, was first approved for use by the US Food and Drug Administration on March 27, [...]

Free drug samples make you spend more!

Patients who receive free drug samples from their doctors end up having significantly higher out-of-pocket costs for their prescription drugs than people who don’t receive free samples, a new study finds.
In fact, patients who received free samples spent about $166 in out-of-pocket costs on prescription drugs in the six months before receiving the samples, $244 [...]

Fosamax associated with unusual fractures of the thigh bone

In the latest research to cast a shadow on the safety of a popular bone-strengthening medication, researchers report that long-term use of Fosamax is associated with unusual fractures of the thigh bone.
The fractures were low-energy fractures, meaning that they all occurred from a fall from standing height or less, and the bone cracks were in [...]

Tyverb is back in Europe

The European Commission has referred GlaxoSmithKline Plc’s breast cancer treatment Tyverb back for a fresh assessment by drugs regulators following new data from Europe’s biggest pharmaceuticals company.
Glaxo said on Tuesday that Tyverb, which is already on sale in the United States under the name Tykerb, had been referred back to the EU’s Committee for Medicinal [...]

Heparin being tested again

U.S. health officials have ordered all imports of the blood thinner heparin, and its raw ingredient, stopped at the border for testing to detect a contaminant linked to 19 deaths.
The Food and Drug Administration announced the move Friday, the latest step in its widening investigation of hundreds of allergic-type reactions linked to Baxter International’s heparin [...]

Blockbuster anemia drugs may lead to death

Drug maker Amgen Inc. said Friday it expanded black box warnings about risks of death and tumor growth of its blockbuster anemia drugs.
The warnings approved by the Food and Drug Administration state that the company’s drugs increased death and accelerated tumor growth in patients with early stage breast cancer and cervical cancer. Earlier labeling warned [...]